JC Virus-Specific Cytotoxic T Lymphocytes in Individuals with Progressive Multifocal Leukoencephalopathy
Open Access
- 1 April 2001
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 75 (7), 3483-3487
- https://doi.org/10.1128/jvi.75.7.3483-3487.2001
Abstract
Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the central nervous system caused by a reactivation of the polyomavirus JC (JCV) within a setting of immunosuppression. The nature of the immune response that contains replication of this virus is unknown. We have explored JCV-specific cellular immune responses in patients with PML and control subjects. JCV antigen-stimulated peripheral blood mononuclear cells (PBMC) of four human immunodeficiency virus (HIV)-infected patients who were survivors of PML and one HIV-uninfected patient recently diagnosed with PML lysed autologous B-lymphoblastoid cell lines expressing either the JCV T regulatory protein or the VP1 major capsid protein. This lysis was mediated by CD8+T lymphocytes and was major histocompatibility complex class I restricted. These cells were therefore cytotoxic T lymphocytes (CTL). JCV-specific CTL could not be detected in PBMC of three HIV-infected PML patients who had progressive neurologic disease and an eventual fatal outcome. These data suggest that the JCV-specific cellular immune response may play a crucial role in the containment of PML. This finding may also prove useful as a favorable prognostic marker in the clinical management of these patients.Keywords
This publication has 24 references indexed in Scilit:
- AIDS-related focal brain lesions in the era of highly active antiretroviral therapyNeurology, 2000
- Highly Active Antiretroviral Therapy and Progressive Multifocal Leukoencephalopathy: Effects on Cerebrospinal Fluid Markers of JC Virus Replication and Immune ResponseClinical Infectious Diseases, 2000
- Notes Progressive Multifocal Leukoencephalopathy in Patients with AIDS Receiving Highly Active Antiretroviral TherapyClinical Infectious Diseases, 1999
- Detection of JC virus DNA in peripheral blood cell subpopulations of HIV-1-infected individualsJournal of NeuroVirology, 1999
- Reversal of Age-Related Deficient Influenza Virus-Specific CTL Responses and IFN-γ Production by Monophosphoryl Lipid ACellular Immunology, 1996
- Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathyAnnals of Neurology, 1992
- Progressive multifocal leukoencephalopathyNeurology, 1978
- Multiple central nervous system infections in progressive multifocal leukoencephalopathyNeurology, 1976
- Progressive multifocal leucoencephalopathy: remission with cytarabine.Journal of Neurology, Neurosurgery & Psychiatry, 1975
- CULTIVATION OF PAPOVA-LIKE VIRUS FROM HUMAN BRAIN WITH PROGRESSIVE MULTIFOCAL LEUCOENCEPHALOPATHYThe Lancet, 1971